Star Staining for CAR-T research

“Star Staining” is the new-generation site-specific labeling technology platform and a series of exclusive fluorescent-labeled proteins developed and specifically designed for the quality control and clinical trials in the research of cell therapy, controlled by ACROBiosystems’ “Star standard”. It is specially designed for the quality control and clinical trials in the research of cell therapy.

Highlights:

• Using new-generation site-specific labeling technology to keep natural bioactivity
• High specificity and sensitivity verified by flow cytometry
• Non-specific binding to non-transduced PBMCs
• High batch-to-batch consistency and uniformity for clinical trials.